mTOR Signaling and Cancer Progression
mTOR Signaling and Cancer Progression
Targeted Cancer Therapies
Targeted Cancer Therapies
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 14, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
Larissa Kotelevets1, Mark G H Scott2, Eric Chastre1
1Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), UMR_S938, 75012 Paris, France.
PTEN (phosphatase and tensin homolog deleted on chromosome ten) is a crucial tumor suppressor gene. Its discovery in 1997 at chromosome 10q23 marked a significant advancement in understanding cancer genetics.
Area of Science:
Background:
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020